메뉴 건너뛰기




Volumn 14, Issue 4, 2017, Pages 375-381

Response to Indacaterol/Glycopyrronium (IND/GLY) by Sex in Patients with COPD: A Pooled Analysis from the IGNITE Program

Author keywords

COPD; gender; IND GLY; sex difference; women

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; FLUTICASONE PROPIONATE PLUS SALMETEROL; GLYCOPYRRONIUM; GLYCOPYRRONIUM BROMIDE PLUS INDACATEROL; INDACATEROL; TIOTROPIUM BROMIDE; GLUCOCORTICOID; INDACATEROL-GLYCOPYRRONIUM COMBINATION; INDAN DERIVATIVE; MUSCARINIC RECEPTOR BLOCKING AGENT; QUINOLONE DERIVATIVE;

EID: 85020407523     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.1080/15412555.2017.1324837     Document Type: Article
Times cited : (33)

References (33)
  • 1
    • 84996602597 scopus 로고    scopus 로고
    • Sex difference in chronic obstructive lung disease. Does it matter?
    • Kokturk N, Kilic H, Baha A, Lee SD, Jones PW. Sex difference in chronic obstructive lung disease. Does it matter? A concise review. COPD. 2016; 13(6):799–806.
    • (2016) A concise review. COPD. , vol.13 , Issue.6 , pp. 799-806
    • Kokturk, N.1    Kilic, H.2    Baha, A.3    Lee, S.D.4    Jones, P.W.5
  • 2
    • 84921407489 scopus 로고    scopus 로고
    • Mortality trends in women and men with COPD in Ontario, Canada, 1996–2012
    • Gershon A, Hwee J, Victor JC, Wilton A, Wu R, Day A, et al. Mortality trends in women and men with COPD in Ontario, Canada, 1996–2012. Thorax. 2015; 70(2):121–126.
    • (2015) Thorax. , vol.70 , Issue.2 , pp. 121-126
    • Gershon, A.1    Hwee, J.2    Victor, J.C.3    Wilton, A.4    Wu, R.5    Day, A.6
  • 3
    • 84901408169 scopus 로고    scopus 로고
    • Cigarette smoking among women: how can we help?
    • Allen SS. Cigarette smoking among women:how can we help? Minn Med. 2014; 97(3):41–43.
    • (2014) Minn Med. , vol.97 , Issue.3 , pp. 41-43
    • Allen, S.S.1
  • 5
    • 0025809099 scopus 로고
    • Increased susceptibility to lung dysfunction in female smokers
    • Chen Y, Horne SL, Dosman JA. Increased susceptibility to lung dysfunction in female smokers. Am Rev Respir Dis. 1991; 143(6):1224–1230.
    • (1991) Am Rev Respir Dis. , vol.143 , Issue.6 , pp. 1224-1230
    • Chen, Y.1    Horne, S.L.2    Dosman, J.A.3
  • 6
    • 33645775057 scopus 로고    scopus 로고
    • Female smokers beyond the perimenopausal period are at increased risk of chronic obstructive pulmonary disease: a systematic review and meta-analysis
    • Gan WQ, Man SF, Postma DS, Camp P, Sin DD. Female smokers beyond the perimenopausal period are at increased risk of chronic obstructive pulmonary disease:a systematic review and meta-analysis. Respir Res. 2006; 7:52.
    • (2006) Respir Res. , vol.7 , pp. 52
    • Gan, W.Q.1    Man, S.F.2    Postma, D.S.3    Camp, P.4    Sin, D.D.5
  • 7
    • 84862954728 scopus 로고    scopus 로고
    • Gender differences in susceptibility to smoking among patients with lung cancer
    • Ryu JS, Jeon SH, Kim JS, Lee JH, Kim SH, Hong JT, et al. Gender differences in susceptibility to smoking among patients with lung cancer. Korean J Intern Med. 2011; 26(4):427–431.
    • (2011) Korean J Intern Med. , vol.26 , Issue.4 , pp. 427-431
    • Ryu, J.S.1    Jeon, S.H.2    Kim, J.S.3    Lee, J.H.4    Kim, S.H.5    Hong, J.T.6
  • 8
    • 84857888066 scopus 로고    scopus 로고
    • Sex differences and sex steroids in lung health and disease
    • Townsend EA, Miller VM, Prakash YS. Sex differences and sex steroids in lung health and disease. Endocr Rev. 2012; 33(1):1–47.
    • (2012) Endocr Rev. , vol.33 , Issue.1 , pp. 1-47
    • Townsend, E.A.1    Miller, V.M.2    Prakash, Y.S.3
  • 9
    • 85027463833 scopus 로고    scopus 로고
    • Chronic obstructive pulmonary disease: the impact of gender
    • Raghavan D, Varkey A, Bartter T. Chronic obstructive pulmonary disease:the impact of gender. Curr Opin Pulm Med. 2016; 10(2):98–103.
    • (2016) Curr Opin Pulm Med. , vol.10 , Issue.2 , pp. 98-103
    • Raghavan, D.1    Varkey, A.2    Bartter, T.3
  • 12
    • 84880229392 scopus 로고    scopus 로고
    • Dual bronchodilation with QVA149 versus single bronchodilator therapy: the SHINE study
    • Bateman ED, Ferguson GT, Barnes N, Gallagher N, Green Y, Henley M, et al. Dual bronchodilation with QVA149 versus single bronchodilator therapy:the SHINE study. Eur Respir J. 2013; 42(6):1484–1494.
    • (2013) Eur Respir J. , vol.42 , Issue.6 , pp. 1484-1494
    • Bateman, E.D.1    Ferguson, G.T.2    Barnes, N.3    Gallagher, N.4    Green, Y.5    Henley, M.6
  • 13
    • 84884819644 scopus 로고    scopus 로고
    • Safety and efficacy of dual bronchodilation with QVA149 in COPD patients: the ENLIGHTEN study
    • Dahl R, Chapman KR, Rudolf M, Mehta R, Kho P, Alagappan VK, et al. Safety and efficacy of dual bronchodilation with QVA149 in COPD patients:the ENLIGHTEN study. Respir Med. 2013; 107(10):1558–1567.
    • (2013) Respir Med. , vol.107 , Issue.10 , pp. 1558-1567
    • Dahl, R.1    Chapman, K.R.2    Rudolf, M.3    Mehta, R.4    Kho, P.5    Alagappan, V.K.6
  • 14
    • 84877131237 scopus 로고    scopus 로고
    • Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group study
    • Wedzicha JA, Decramer M, Ficker JH, Niewoehner DE, Sandstrom T, Taylor AF, et al. Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK):a randomised, double-blind, parallel-group study. Lancet Respir Med. 2013; 1(3):199–209.
    • (2013) Lancet Respir Med. , vol.1 , Issue.3 , pp. 199-209
    • Wedzicha, J.A.1    Decramer, M.2    Ficker, J.H.3    Niewoehner, D.E.4    Sandstrom, T.5    Taylor, A.F.6
  • 15
    • 84933526262 scopus 로고    scopus 로고
    • LANTERN: a randomized study of QVA149 versus salmeterol/fluticasone combination in patients with COPD
    • Zhong N, Wang C, Zhou X, Zhang N, Humphries M, Wang L, et al. LANTERN:a randomized study of QVA149 versus salmeterol/fluticasone combination in patients with COPD. Int J Chron Obstruct Pulm Dis. 2015; 10:1015–1026.
    • (2015) Int J Chron Obstruct Pulm Dis. , vol.10 , pp. 1015-1026
    • Zhong, N.1    Wang, C.2    Zhou, X.3    Zhang, N.4    Humphries, M.5    Wang, L.6
  • 16
    • 84877676197 scopus 로고    scopus 로고
    • Efficacy and safety of once-daily QVA149 compared with twice-daily salmeterol-fluticasone in patients with chronic obstructive pulmonary disease (ILLUMINATE): a randomised, double-blind, parallel group study
    • Vogelmeier CF, Bateman ED, Pallante J, Alagappan VK, D'Andrea P, Chen H, et al. Efficacy and safety of once-daily QVA149 compared with twice-daily salmeterol-fluticasone in patients with chronic obstructive pulmonary disease (ILLUMINATE):a randomised, double-blind, parallel group study. Lancet Respir Med. 2013; 1(1):51–60.
    • (2013) Lancet Respir Med. , vol.1 , Issue.1 , pp. 51-60
    • Vogelmeier, C.F.1    Bateman, E.D.2    Pallante, J.3    Alagappan, V.K.4    D'Andrea, P.5    Chen, H.6
  • 17
    • 84994164544 scopus 로고    scopus 로고
    • Efficacy and safety of indacaterol/glycopyrronium in Japanese patients with COPD: Pooled analysis of SHINE and ARISE
    • Asai K, Hirata K, Hashimoto S, Fukuchi Y, Kitawaki T, Ikeda K, et al. Efficacy and safety of indacaterol/glycopyrronium in Japanese patients with COPD:Pooled analysis of SHINE and ARISE. Respir Investig. 2016; 54(6):428–435.
    • (2016) Respir Investig. , vol.54 , Issue.6 , pp. 428-435
    • Asai, K.1    Hirata, K.2    Hashimoto, S.3    Fukuchi, Y.4    Kitawaki, T.5    Ikeda, K.6
  • 20
    • 13444250953 scopus 로고    scopus 로고
    • The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial
    • Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connett JE, et al. The effects of a smoking cessation intervention on 14.5-year mortality:a randomized clinical trial. Ann Intern Med. 2005; 142(4):233–239.
    • (2005) Ann Intern Med. , vol.142 , Issue.4 , pp. 233-239
    • Anthonisen, N.R.1    Skeans, M.A.2    Wise, R.A.3    Manfreda, J.4    Kanner, R.E.5    Connett, J.E.6
  • 22
    • 79551509360 scopus 로고    scopus 로고
    • Sex differences in mortality and clinical expressions of patients with chronic obstructive pulmonary disease. The TORCH experience
    • Celli B, Vestbo J, Jenkins CR, Jones PW, Ferguson GT, Calverley PM, et al. Sex differences in mortality and clinical expressions of patients with chronic obstructive pulmonary disease. The TORCH experience. Am J Respir Crit Care Med. 2011; 183(3):317–322.
    • (2011) Am J Respir Crit Care Med. , vol.183 , Issue.3 , pp. 317-322
    • Celli, B.1    Vestbo, J.2    Jenkins, C.R.3    Jones, P.W.4    Ferguson, G.T.5    Calverley, P.M.6
  • 24
    • 0037252102 scopus 로고    scopus 로고
    • The risk of osteoporosis in Caucasian men and women with obstructive airways disease
    • Sin DD, Man JP, Man SF. The risk of osteoporosis in Caucasian men and women with obstructive airways disease. Am J Med. 2003; 114(1):10–14.
    • (2003) Am J Med. , vol.114 , Issue.1 , pp. 10-14
    • Sin, D.D.1    Man, J.P.2    Man, S.F.3
  • 25
    • 84939514891 scopus 로고    scopus 로고
    • Chronic obstructive pulmonary disease and allied conditions is a strong independent risk factor for osteoporosis and pathologic fractures: a population-based cohort study
    • Chen SJ, Liao WC, Huang KH, Lin CL, Tsai WC, Kung PT, et al. Chronic obstructive pulmonary disease and allied conditions is a strong independent risk factor for osteoporosis and pathologic fractures:a population-based cohort study. QJM. 2015; 108(8):633–640.
    • (2015) QJM. , vol.108 , Issue.8 , pp. 633-640
    • Chen, S.J.1    Liao, W.C.2    Huang, K.H.3    Lin, C.L.4    Tsai, W.C.5    Kung, P.T.6
  • 27
    • 84937164147 scopus 로고    scopus 로고
    • Women with severe obesity and relatively low bone mineral density have increased fracture risk
    • Cawsey S, Padwal R, Sharma AM, Wang X, Li S, Siminoski K. Women with severe obesity and relatively low bone mineral density have increased fracture risk. Osteoporos Int. 2015; 26(1):103–111.
    • (2015) Osteoporos Int. , vol.26 , Issue.1 , pp. 103-111
    • Cawsey, S.1    Padwal, R.2    Sharma, A.M.3    Wang, X.4    Li, S.5    Siminoski, K.6
  • 28
    • 1542301591 scopus 로고    scopus 로고
    • Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase
    • Barnes PJ, Ito K, Adcock IM. Corticosteroid resistance in chronic obstructive pulmonary disease:inactivation of histone deacetylase. Lancet. 2004; 363(9410):731–733.
    • (2004) Lancet. , vol.363 , Issue.9410 , pp. 731-733
    • Barnes, P.J.1    Ito, K.2    Adcock, I.M.3
  • 29
    • 84855896477 scopus 로고    scopus 로고
    • The effects of cigarette smoke on airway inflammation in asthma and COPD: therapeutic implications
    • Tamimi A, Serdarevic D, Hanania NA. The effects of cigarette smoke on airway inflammation in asthma and COPD:therapeutic implications. Respir Med. 2012; 106(3):319–328.
    • (2012) Respir Med. , vol.106 , Issue.3 , pp. 319-328
    • Tamimi, A.1    Serdarevic, D.2    Hanania, N.A.3
  • 31
    • 84903812277 scopus 로고    scopus 로고
    • Withdrawal of inhaled corticosteroids can be safe in COPD patients at low risk of exacerbation: a real-life study on the appropriateness of treatment in moderate COPD patients (OPTIMO)
    • Rossi A, Guerriero M, Corrado A, Group OAS. Withdrawal of inhaled corticosteroids can be safe in COPD patients at low risk of exacerbation:a real-life study on the appropriateness of treatment in moderate COPD patients (OPTIMO). Respir Res. 2014; 15:77.
    • (2014) Respir Res. , vol.15 , pp. 77
    • Rossi, A.1    Guerriero, M.2    Corrado, A.3    Group, O.A.S.4
  • 32
    • 84916240063 scopus 로고    scopus 로고
    • INSTEAD: a randomised switch trial of indacaterol versus salmeterol/fluticasone in moderate COPD
    • Rossi A, van der Molen T, del Olmo R, Papi A, Wehbe L, Quinn M, et al. INSTEAD:a randomised switch trial of indacaterol versus salmeterol/fluticasone in moderate COPD. Eur Respir J. 2014; 44(6):1548–1556.
    • (2014) Eur Respir J. , vol.44 , Issue.6 , pp. 1548-1556
    • Rossi, A.1    van der Molen, T.2    del Olmo, R.3    Papi, A.4    Wehbe, L.5    Quinn, M.6
  • 33
    • 85014789444 scopus 로고    scopus 로고
    • Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD EXECUTIVE SUMMARY
    • Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report:GOLD EXECUTIVE SUMMARY. Am J Respir Crit Care Med. 2017; 195(5):557–582.
    • (2017) Am J Respir Crit Care Med. , vol.195 , Issue.5 , pp. 557-582
    • Vogelmeier, C.F.1    Criner, G.J.2    Martinez, F.J.3    Anzueto, A.4    Barnes, P.J.5    Bourbeau, J.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.